Madrigal Pharmaceuticals, Inc. (MDGL) Dividend History
Income profile from 2003 to 2025 with payout safety and yield-on-cost trend
MDGL Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
1 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
MDGL Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
MDGL Dividend History
No dividend payment history available
Dividend Analysis
Payout Safety
Madrigal Pharmaceuticals, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 3/9 — weak financial health.
Growth Track Record
MDGL has raised its dividend for 1 consecutive year.
Total Shareholder Returns
Beyond cash dividends, MDGL returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 326.0%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $385,522 today.
MDGL Annual Dividend History (2003–2025)
23 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-12.85 | — | — | — |
| 2024 | $0.00 | — | 0 | $-21.90 | — | — | — |
| 2023 | $0.00 | — | 0 | $-19.99 | — | — | — |
| 2022 | $0.00 | — | 0 | $-17.23 | — | — | — |
| 2021 | $0.00 | — | 0 | $-14.63 | — | — | — |
| 2020 | $0.00 | — | 0 | $-13.09 | — | — | — |
| 2019 | $0.00 | — | 0 | $-4.73 | — | — | — |
| 2018 | $0.00 | — | 0 | $-2.22 | — | — | — |
| 2017 | $0.00 | — | 0 | $-2.54 | — | — | — |
| 2016 | $0.00 | — | 0 | $-5.07 | — | — | — |
Full MDGL Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See MDGL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MDGL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MDGL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMDGL — Frequently Asked Questions
Quick answers to the most common questions about buying MDGL stock.
How much dividend does MDGL pay per share?
Madrigal Pharmaceuticals, Inc. (MDGL) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is MDGL's next ex-dividend date?
MDGL's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. MDGL typically pays dividends quarterly.
Is MDGL's dividend safe?
MDGL's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The 1-year growth streak provides moderate confidence.
How many years has MDGL increased its dividend?
MDGL has 1 consecutive years of dividend growth. The 5-year dividend CAGR is N/A.
How often does MDGL pay dividends?
Madrigal Pharmaceuticals, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 22+ years from 2003 to 2025.
How much would $10,000 invested in MDGL grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in MDGL five years ago would be worth approximately $42,596 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is MDGL's yield on cost for long-term holders?
MDGL's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.